North American Market Forecast
North America industry is predicted to account for largest revenue share by 2037. The growth of the market can be attributed majorly to the increasing prevalence of renal cell carcinoma and other cancers in the region. For instance, in 2022, about 79,000 new cases of kidney cancer are expected to be diagnosed, out of which, 50,290 cases in men and 28,710 in women are anticipated to be diagnosed. Along with this, close to 13,920 deaths are anticipated to be caused by kidney cancer. Besides this, the rising adoption of advanced therapeutics, along with the surge in novel product approval are some major factors that are estimated to boost the market growth further during the projected time frame. In addition to this, the presence of significant key players is also anticipated to boost market growth during the forecast period.
APAC Market Statistics
The Asia Pacific advanced renal cell carcinoma treatment market, amongst the market in all the other regions, is projected to grow with a notable CAGR during the forecast period. The growth of the market can be attributed majorly to the increasing frequency of kidney cancer cases in the region, followed by the radical growth in the healthcare sector in the region. Moreover, an upsurge in the sedentary lifestyle of individuals is also projected to further fuel the growth of the advanced renal cell carcinoma treatment market in the APAC region during the forecast period.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?